SCHEMBL28920176

SCHEMBL28920176

N#Cc1c(Cl)cc(N)cc1Br

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 5/20 0.41
ALDH1A1 P00352 2/20 0.41
MAPT P10636 2/20 0.41
GAA P10253 1/20 0.41
THRB P10828 1/20 0.38
MAPK14 Q16539 1/20 0.35
TSHR P16473 1/20 0.33
HTT P42858 1/20 0.33
MDM4 O15151 1/20 0.32
TP53 P04637 2/20 0.32
L3MBTL1 Q9Y468 2/20 0.32
TDP1 Q9NUW8 1/20 0.32
KMT2A Q03164 3/20 0.31
HPGD P15428 2/20 0.31
ADORA2A P29274 2/20 0.31
ADORA1 P30542 2/20 0.31
LMNA P02545 1/20 0.31
MEN1 O00255 2/20 0.31
MAPK1 P28482 1/20 0.31
SMN1; SMN2 Q16637 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1810815 0.84 CYP3A4 (0.50) CYP3A4ALDH1A1MAPTGAATHRB
SCHEMBL2947899 0.78 ALDH1A1 (0.36) CYP3A4ALDH1A1MAPTMAPK14TSHR
SCHEMBL4515950 0.77 CYP3A4 (0.42) CYP3A4ALDH1A1MAPTTHRBTSHR
SCHEMBL1808542 0.75 TRPV4 (0.43) CYP3A4ALDH1A1MAPTGAATHRB
SCHEMBL29739381 0.75 KDM4E (0.46) CYP3A4ALDH1A1MAPTTHRBTSHR
SCHEMBL30567328 0.73 CA1 (0.36) CYP3A4ALDH1A1MAPTGAAMAPK14
SCHEMBL20680954 0.73 CA1 (0.36) CYP3A4ALDH1A1MAPTGAAMAPK14
SCHEMBL14744340 0.71 CYP3A4 (0.41) CYP3A4ALDH1A1MAPTGAATHRB
SCHEMBL16335716 0.71 MAPK14 (0.38) CYP3A4ALDH1A1MAPTGAAMAPK14
SCHEMBL12145447 0.71 CYP3A4 (0.37) CYP3A4ALDH1A1THRBTSHRMDM4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115490709-A KRASG12D inhibitor and application thereof in medicine 四川海思科制药有限公司 2022-12-20 CN disclosed